Back to Journals » OncoTargets and Therapy » Volume 18
Upregulation of SHIP2 Participates in the Development of Breast Cancer via Promoting Wnt/β-Catenin Signaling [Retraction]
Received 5 August 2025
Accepted for publication 5 August 2025
Published 7 August 2025 Volume 2025:18 Pages 863—864
This retraction applies to:
published online on 30/08/2019Zhou J, Di M, Han H. Onco Targets Ther. 2019;12:7067–7077.
We, the Editors and Publisher of the journal OncoTargets and Therapy have retracted the published article.
Following publication, image integrity concerns were raised regarding Figures 2C, 2D, 2F, 3A, 3C, 4, 5B, 6A and 6D. The authors also contacted the journal to request a withdrawal of their article and later requested a correction to Figure 6A.
When asked for further information and an explanation for the image concerns, the authors were unable to address the concerns raised.
As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors listed in this publication have been informed. The corresponding author has agreed to retract the article.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
This retraction relates to this paper
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.